Further, NHP plasma capability to inhibit the viral infection to the cells was tested in vitro using an early circulating strain of SARS-CoV-2 viruses and VeroE6 constitutively expressing transmembrane protease, serine 2 (TMPRSS2) for facilitating the infection (Figure 3F). This evidence concerns the gene TMPRSS2 and viral infectious disease.